ATE291913T1 - Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen - Google Patents

Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen

Info

Publication number
ATE291913T1
ATE291913T1 AT01906672T AT01906672T ATE291913T1 AT E291913 T1 ATE291913 T1 AT E291913T1 AT 01906672 T AT01906672 T AT 01906672T AT 01906672 T AT01906672 T AT 01906672T AT E291913 T1 ATE291913 T1 AT E291913T1
Authority
AT
Austria
Prior art keywords
contact lenses
preparations suitable
ophthalmic preparations
antiallergic
antiallergic ophthalmic
Prior art date
Application number
AT01906672T
Other languages
German (de)
English (en)
Inventor
John M Yanni
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of ATE291913T1 publication Critical patent/ATE291913T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01906672T 2000-01-25 2001-01-24 Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen ATE291913T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17780400P 2000-01-25 2000-01-25
PCT/US2001/002418 WO2001054687A1 (en) 2000-01-25 2001-01-24 Ophthalmic anti-allergy compositions suitable for use with contact lenses

Publications (1)

Publication Number Publication Date
ATE291913T1 true ATE291913T1 (de) 2005-04-15

Family

ID=22650044

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01906672T ATE291913T1 (de) 2000-01-25 2001-01-24 Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen

Country Status (10)

Country Link
US (1) US6375973B2 (cg-RX-API-DMAC7.html)
EP (1) EP1250133B1 (cg-RX-API-DMAC7.html)
JP (2) JP2003520813A (cg-RX-API-DMAC7.html)
AT (1) ATE291913T1 (cg-RX-API-DMAC7.html)
AU (1) AU776789B2 (cg-RX-API-DMAC7.html)
CA (1) CA2395866C (cg-RX-API-DMAC7.html)
DE (1) DE60109742T2 (cg-RX-API-DMAC7.html)
ES (1) ES2236180T3 (cg-RX-API-DMAC7.html)
PT (1) PT1250133E (cg-RX-API-DMAC7.html)
WO (1) WO2001054687A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
US9238003B2 (en) 2005-02-04 2016-01-19 Auburn University Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules
US8349352B2 (en) * 2005-02-04 2013-01-08 Auburn University Therapeutic contact lenses with anti-fungal delivery
CA2597219C (en) * 2005-02-04 2014-04-15 Auburn University Contact drug delivery system
US8388995B1 (en) 2006-02-03 2013-03-05 Auburn University Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform
US7947010B2 (en) * 2005-07-08 2011-05-24 Depuy Products, Inc. Composition and system for wound decontamination
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
US20080138408A1 (en) 2006-11-13 2008-06-12 Siddharth Venkatesh Drug delivery system and method
SI2114367T1 (sl) * 2007-02-07 2016-01-29 Novartis Ag Formulacije olopatadina za topično nazalno dajanje
AU2011282252B2 (en) * 2010-07-21 2014-08-21 Alcon Research, Ltd. Pharmaceutical composition with enhanced solubility characteristics
TWI544922B (zh) * 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
WO2014150899A1 (en) * 2013-03-15 2014-09-25 Chapin Matthew J Topical ophthalmic formulations for treating migraine
CA2929074A1 (en) * 2013-10-31 2015-05-07 Nephron Pharmaceuticals Corporation Formulation of olopatadine
EP3037094A1 (en) 2014-12-23 2016-06-29 Poifa Warszawa SA Ophthalmic pharmaceutical composition
CN107875119B (zh) * 2017-11-22 2021-03-12 山东绅联药业有限公司 一种富马酸依美斯汀水性药物组合物及其制备方法
WO2025137749A1 (pt) * 2023-12-27 2025-07-03 Eurofarma Laboratórios S.A. Processo de solubilização de olopatadina e seu uso

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027020A (en) 1974-10-29 1977-05-31 Millmaster Onyx Corporation Randomly terminated capped polymers
US3931319A (en) 1974-10-29 1976-01-06 Millmaster Onyx Corporation Capped polymers
US4525346A (en) * 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4407791A (en) * 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
JPS5879983A (ja) 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
US4836986A (en) 1984-09-28 1989-06-06 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPH08770B2 (ja) * 1985-12-25 1996-01-10 千寿製薬株式会社 眼科用組成物
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
US5037647A (en) 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
AU636685B2 (en) * 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
US5192780A (en) 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
US5145643A (en) 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
CA2132826C (en) 1992-05-06 1999-01-05 Masood Chowhan Use of borate-polyol complexes in ophthalmic compositions
US5300287A (en) 1992-11-04 1994-04-05 Alcon Laboratories, Inc. Polymeric antimicrobials and their use in pharmaceutical compositions
JP3527256B2 (ja) * 1992-12-09 2004-05-17 ロート製薬株式会社 抗アレルギー点眼剤
US5668133A (en) 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
US5370744B1 (en) * 1993-08-27 1999-11-09 Alcon Lab Inc Process for cleaning and disinfecting contact lenses
US5603929A (en) * 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
BR9711406A (pt) * 1996-09-20 1999-08-17 Bausch & Lomb Sistema e m-todo para reumidifica-Æo de lentes de contato e alivio da secura dos olhos
ZA9811445B (en) * 1997-12-19 1999-08-16 Alcon Lab Inc Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
ES2203103T3 (es) * 1998-04-07 2004-04-01 Alcon Manufacturing Ltd. Composiciones oftalmicas gelificantes que contienen goma xantana.
JP3407654B2 (ja) * 1998-04-14 2003-05-19 ライオン株式会社 眼科用組成物
US6146622A (en) * 1998-10-27 2000-11-14 Alcon Laboratories, Inc. Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions

Also Published As

Publication number Publication date
DE60109742T2 (de) 2005-08-18
PT1250133E (pt) 2005-05-31
DE60109742D1 (de) 2005-05-04
WO2001054687A1 (en) 2001-08-02
AU3455601A (en) 2001-08-07
EP1250133A1 (en) 2002-10-23
EP1250133B1 (en) 2005-03-30
US6375973B2 (en) 2002-04-23
US20010056093A1 (en) 2001-12-27
JP2011132259A (ja) 2011-07-07
CA2395866C (en) 2009-10-13
AU776789B2 (en) 2004-09-23
ES2236180T3 (es) 2005-07-16
JP2003520813A (ja) 2003-07-08
CA2395866A1 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
DE60109742D1 (de) Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
NO20032816D0 (no) Kontaktlinse med opakt irismönster
SV2001000288A (es) 3- aminoquinazolin - 2, 4 - dione agentes antibacteriales
MXPA03004041A (es) Lentes oftalmicas sin union y metodos para su produccion.
AU2001283386A1 (en) Presbyopia treatment by lens alteration
DE60139944D1 (de) Niederviskose konzentrierte proteinformulierungen
DE69317537D1 (de) Antiallergische Zusammensetzung zur ophthalmischen oder nasalen Anwendung
CY1109972T1 (el) Χρηση τοξινης αλλαντιασης για τη θεραπευτικη αγωγη του πονου της νεραλγιας
AU8676401A (en) Ophthalmic lenses useful in correcting astigmatism and presbyopia
AU5498201A (en) Ophthalmic lens injectors
BR0016386A (pt) Lentes oftálmicas multifocais birrefringentes refrativas hìbridas
MX9204082A (es) Lentes oftalmicos mixtos.
AU2001233154A1 (en) Intraocular multifocal lens construction
ECSP044862A (es) Pirenzepine ophthalmic gel
WO2002096367A3 (en) Targeted multivalent macromolecules
HK1041924A1 (zh) 具有修正的通道焦度曲綫的渐增透镜
FR2810231B1 (fr) Cornee synthetique
BR0115882A (pt) Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
DK1244438T3 (da) Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde
ATE305796T1 (de) Präparationen von vitamin e in kombination mit afamin
FR2803922B1 (fr) Lentille ophtalmique
ES2197018A1 (es) Nuevo uso terapeutico de los extractos de polypodium.
Evans Women's Cultural Agency in British India: Challenging Indian Culture with Female Education
AR026114A1 (es) Lentes de contacto con el borde posterior elevado

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1250133

Country of ref document: EP